CDER Conversation: Information Visualization Platform (InfoViP): CDER’s New Artificial Intelligence Safety Surveillance Tool - Drug Information Update

CDER Conversation: Information Visualization Platform (InfoViP): CDER's New Artificial Intelligence Safety Surveillance Tool

If your email program has trouble displaying this email, view it as a web page. CDER Conversation: Information Visualization Platform (InfoViP): CDER's New Artificial Intelligence Safety Surveillance Tool In this CDER Conversation, Oanh Dang of the Office of Surveillance and Epidemiology's (OSE) Regulatory Science Staff, shares how the Information Visualization Platform (InfoViP) demonstrates the value of artificial intelligence (AI) for increasing the efficiency of FDA's reviews and how the safety surveillance tool impacts public health. OSE and Johns Hopkins University developed the InfoViP to investigate the value of AI in postmarket surveillance. InfoViP incorporates AI and advanced visualizations to support OSE safety reviewer's examination of data or content to discover deeper insights, make predictions, or generate recommendations to support postmarket safety surveillance. Learn More This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. Stay Connected with U.S. Food and Drug Administration:         SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA